Receptor: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (6 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
=[[Transmembrane (cell surface) receptors]]= | =[[Transmembrane (cell surface) receptors]]= | ||
See also [[Membrane proteins]]. | See also [[Membrane proteins]]. | ||
==[[Integrin]]== | |||
==Ion channel-linked (ionotropic) receptors== | ==Ion channel-linked (ionotropic) receptors== | ||
These receptors are typically the targets of fast neurotransmitters such as acetylcholine (nicotinic) and GABA; activation of these receptors results in changes in ion movement across a membrane. | These receptors are typically the targets of fast neurotransmitters such as acetylcholine (nicotinic) and GABA; activation of these receptors results in changes in ion movement across a membrane. | ||
*[[Ionotropic receptors]] | *[[Ionotropic receptors]] | ||
*[[Journal:Acta Cryst D:S205979832000772X|Structural evidence for mono- and di-carboxylates binding at pharmacologically relevant extracellular sites of a pentameric ligand gated ion channel]] | |||
*[[5-hydroxytryptamine receptor#Structural highlights/Specific Function of 5-HT3]] | *[[5-hydroxytryptamine receptor#Structural highlights/Specific Function of 5-HT3]] | ||
*[[Journal:JBSD:16|The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study]]<ref>DOI 10.1080/07391102.2012.680029</ref> | *[[Journal:JBSD:16|The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study]]<ref>DOI 10.1080/07391102.2012.680029</ref> | ||
| Line 115: | Line 117: | ||
*Isoprenaline: [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y03]] | *Isoprenaline: [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y03]] | ||
*Carmoterol: [[2y02]] | *Carmoterol: [[2y02]] | ||
*Salbutamol: [[2y04]] | *[[Salbutamol]]: [[2y04]] | ||
*[[Beta-2 Adrenergic Receptor|Article Beta-2 Adrenergic Receptor by Wayne Decatur, David Canner, Dotan Shaniv, Joel L. Sussman, Michal Harel]] | *[[Beta-2 Adrenergic Receptor|Article Beta-2 Adrenergic Receptor by Wayne Decatur, David Canner, Dotan Shaniv, Joel L. Sussman, Michal Harel]] | ||
*[[Beta-2 adrenergic receptor|Article Beta-2 adrenergic receptor by Joel L. Sussman, Tala Curry, Michal Harel, Jaime Prilusky]] | *[[Beta-2 adrenergic receptor|Article Beta-2 adrenergic receptor by Joel L. Sussman, Tala Curry, Michal Harel, Jaime Prilusky]] | ||
| Line 157: | Line 159: | ||
*[[TrkB tyrosine kinase receptor]] | *[[TrkB tyrosine kinase receptor]] | ||
*[[Toll-like Receptors]] | *[[Toll-like Receptors]] | ||
*[[Abscisic acid receptor]] | |||
==[[Immune receptors]]== | ==[[Immune receptors]]== | ||
===Leukocyte immunoglobulin-like receptors=== | ===Leukocyte immunoglobulin-like receptors=== | ||
*[[Leukocyte immunoglobulin-like receptor]] | *[[Leukocyte immunoglobulin-like receptor]] | ||
===Cytokine receptors=== | ===[[Cytokine receptors]]=== | ||
====TNF receptor superfamily==== | ====TNF receptor superfamily==== | ||
| Line 192: | Line 195: | ||
*[[Transferrin receptor]] | *[[Transferrin receptor]] | ||
=Intracellular receptors= | =[[Intracellular receptors]]= | ||
==Signal recognition particle receptor== | ==Signal recognition particle receptor== | ||
*[[Signal recognition particle receptor]] | *[[Signal recognition particle receptor]] | ||
| Line 224: | Line 227: | ||
*[[Liver receptor homolog-1]]? | *[[Liver receptor homolog-1]]? | ||
==Endoplasmic reticulum/Sarcoplasmic reticulum receptors== | ==[[Endoplasmic reticulum/Sarcoplasmic reticulum receptors]]== | ||
===Ligand-gated Calcium channels=== | ===Ligand-gated Calcium channels=== | ||
